107 related articles for article (PubMed ID: 34470955)
1. Importance of the Azole Moiety of Cimetidine Derivatives for the Inhibition of Human Multidrug and Toxin Extrusion Transporter 1 (hMATE1).
Shinya S; Kawai K; Tarui A; Karuo Y; Sato K; Matsuda M; Kitatani K; Kobayashi N; Nabe T; Otsuka M; Omote M
Chem Pharm Bull (Tokyo); 2021; 69(9):905-912. PubMed ID: 34470955
[TBL] [Abstract][Full Text] [Related]
2. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
Yin J; Duan H; Wang J
J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931
[TBL] [Abstract][Full Text] [Related]
3. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
[TBL] [Abstract][Full Text] [Related]
4. Functional characteristics of two human MATE transporters: kinetics of cimetidine transport and profiles of inhibition by various compounds.
Ohta KY; Inoue K; Yasujima T; Ishimaru M; Yuasa H
J Pharm Pharm Sci; 2009; 12(3):388-96. PubMed ID: 20067714
[TBL] [Abstract][Full Text] [Related]
5. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine.
Matsushima S; Maeda K; Inoue K; Ohta KY; Yuasa H; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Mar; 37(3):555-9. PubMed ID: 19074525
[TBL] [Abstract][Full Text] [Related]
7. Rapid Regulation of Human Multidrug and Extrusion Transporters hMATE1 and hMATE2K.
Kantauskaitė M; Hucke A; Reike M; Ahmed Eltayeb S; Xiao C; Barz V; Ciarimboli G
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708212
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Human Multidrug and Toxic Compound Extrusion (MATE) Transporters in Testosterone Transport.
Goda M; Ikehara M; Sakitani M; Oda K; Ishizawa K; Otsuka M
Biol Pharm Bull; 2021; 44(4):501-506. PubMed ID: 33790101
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
Doki K; Apáti S; Sakata T; Homma M
Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
[TBL] [Abstract][Full Text] [Related]
10. Use of a Double-Transfected System to Predict hOCT2/hMATE1-Mediated Renal Drug-Drug Interactions.
Vieira LS; Wang J
Drug Metab Dispos; 2024 Mar; 52(4):296-304. PubMed ID: 38326034
[TBL] [Abstract][Full Text] [Related]
11. Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.
Li LP; Song FF; Weng YY; Yang X; Wang K; Lei HM; Ma J; Zhou H; Jiang HD
Br J Pharmacol; 2016 Aug; 173(16):2543-54. PubMed ID: 27324234
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1).
Lai Y; Sampson KE; Balogh LM; Brayman TG; Cox SR; Adams WJ; Kumar V; Stevens JC
J Pharmacol Exp Ther; 2010 Sep; 334(3):936-44. PubMed ID: 20519552
[TBL] [Abstract][Full Text] [Related]
13. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
[TBL] [Abstract][Full Text] [Related]
14. Components of foods inhibit a drug exporter, human multidrug and toxin extrusion transporter 1.
Kawasaki T; Ito H; Omote H
Biol Pharm Bull; 2014; 37(2):292-7. PubMed ID: 24492725
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins.
Yasujima T; Ohta KY; Inoue K; Ishimaru M; Yuasa H
Drug Metab Dispos; 2010 Apr; 38(4):715-21. PubMed ID: 20047987
[TBL] [Abstract][Full Text] [Related]
16. Multidrug and toxin extrusion proteins mediate cellular transport of cadmium.
Yang H; Guo D; Obianom ON; Su T; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2017 Jan; 314():55-62. PubMed ID: 27871888
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.
Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2].
Lei HM; Sun SY; Li LP; Tu MJ; Zhou H; Zeng S; Jiang HD
Yao Xue Xue Bao; 2015 Jul; 50(7):842-7. PubMed ID: 26552145
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters.
Tanihara Y; Masuda S; Sato T; Katsura T; Ogawa O; Inui K
Biochem Pharmacol; 2007 Jul; 74(2):359-71. PubMed ID: 17509534
[TBL] [Abstract][Full Text] [Related]
20. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K
Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
